Welcome to the InfoSci Platform
Reference Hub4
Chitosan and Its Derivatives as Potential Neuro-Protective Agents for the Treatment of Parkinson's Disease

Chitosan and Its Derivatives as Potential Neuro-Protective Agents for the Treatment of Parkinson's Disease

Youssef Ait Hamdan, Samia Elouali, Abdelali Ben Maloui, Bilal El-Mansoury, Hassane Oudadesse, Mohammed Rhazi
Copyright: © 2023 |Pages: 22
ISBN13: 9781668451564|ISBN10: 1668451565|EISBN13: 9781668451571
DOI: 10.4018/978-1-6684-5156-4.ch015
Cite Chapter Cite Chapter

MLA

Hamdan, Youssef Ait, et al. "Chitosan and Its Derivatives as Potential Neuro-Protective Agents for the Treatment of Parkinson's Disease." Experimental and Clinical Evidence of the Neuropathology of Parkinson’s Disease, edited by Ahmed Draoui, et al., IGI Global, 2023, pp. 253-274. https://doi.org/10.4018/978-1-6684-5156-4.ch015

APA

Hamdan, Y. A., Elouali, S., Ben Maloui, A., El-Mansoury, B., Oudadesse, H., & Rhazi, M. (2023). Chitosan and Its Derivatives as Potential Neuro-Protective Agents for the Treatment of Parkinson's Disease. In A. Draoui, O. El Hiba, & A. Jayakumar (Eds.), Experimental and Clinical Evidence of the Neuropathology of Parkinson’s Disease (pp. 253-274). IGI Global. https://doi.org/10.4018/978-1-6684-5156-4.ch015

Chicago

Hamdan, Youssef Ait, et al. "Chitosan and Its Derivatives as Potential Neuro-Protective Agents for the Treatment of Parkinson's Disease." In Experimental and Clinical Evidence of the Neuropathology of Parkinson’s Disease, edited by Ahmed Draoui, Omar El Hiba, and Arumugam R. Jayakumar, 253-274. Hershey, PA: IGI Global, 2023. https://doi.org/10.4018/978-1-6684-5156-4.ch015

Export Reference

Mendeley
Favorite

Abstract

Although Parkinson's disease (PD) is the second most common neurological disorder, it faces a lack of credible medications, treatments, and diagnostics. Many current conventional substances are designed as anti-Parkinson's drugs, but their poor brain transfer across the blood-brain barrier (BBB) and bioavailability are a problem. Recently, chitosan (CTS) and its derivatives from arthropod exoskeletons have attracted much attention because of their neuroprotective effects and their ability to transport therapeutic substances across the BBB. CTS and its derivatives have the ability to inhibit apoptosis, oxidative stress, and neuroinflammation. In addition to these properties, CTS nanoparticles constitute a system for the controlled delivery of therapeutic molecules across the BBB. This chapter will focus on the neuroprotective effects of CTS and its derivatives and their applications in the delivery of certain therapeutic substances.

Request Access

You do not own this content. Please login to recommend this title to your institution's librarian or purchase it from the IGI Global bookstore.